SHE:002873 Revenue

In the year 2025, Guiyang Xintian Pharmaceutical had annual revenue of 749.72M CNY, down -12.57%. Guiyang Xintian Pharmaceutical had revenue of 191.09M in the quarter ending December 31, 2025, a decrease of -2.86%.

Revenue

749.72M

Revenue Growth

-12.57%

P/S Ratio

3.08

Revenue / Employee

540.14K

Employees

1,388

Market Cap

2.31B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	749.72M	-107.83M	-12.57%
Dec 31, 2024	857.55M	-96.43M	-10.11%
Dec 31, 2023	953.98M	-133.69M	-12.29%
Jan 1, 2023	1.09B	117.83M	12.15%
Jan 1, 2022	969.84M	218.90M	29.15%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Zhejiang East Asia Pharmaceutical	940.19M
Jiangsu CoWin Biotech	193.52M
Jiangsu Gdk Biological Technology	110.32M
Shanghai Hile Bio-Technology	246.35M
Shanghai Universal Biotech	1.07B
Suzhou Fushilai Pharmaceutical	412.51M
Cabio Biotech (Wuhan)	418.18M
Jilin Jian Yisheng Pharmaceutical	659.66M

Revenue Rankings